Uncovering the stability status of the reputed reference genes in breast and hepatic cancer cell lines

Gilar Gorji-Bahri; Niloofar Moradtabrizi; Atieh Hashemi

doi:10.1371/journal.pone.0259669

Abstract

Accurate and reliable relative gene expression analysis via the Reverse Transcription-quantitative Real Time PCR (RT-qPCR) method strongly depends on employing several stable reference genes as normalizers. Utilization of the reference genes without analyzing their expression stability under each experimental condition causes RT-qPCR analysis error as well as false output. Similar to cancerous tissues, cancer cell lines also exhibit various gene expression profiles. It is crucial to recognize stable reference genes for well-known cancer cell lines to minimize RT-qPCR analysis error. In this study, we showed the expression level and investigated the expression stability of eight common reference genes that are ACTB, YWHAZ, HPRT1, RNA18S, TBP, GAPDH, UBC, and B2M, in two sets of cancerous cell lines. One set contains MCF7, SKBR3, and MDA-MB231 as breast cancer cell lines. Another set includes three hepatic cancer cell lines, including Huh7, HepG2, and PLC-PRF5. Three excel-based softwares comprising geNorm, BestKeeper, and NormFinder, and an online tool, namely RefFinder were used for stability analysis. Although all four algorithms did not show the same stability ranking of nominee genes, the overall results showed B2M and ACTB as the least stable reference genes for the studied breast cancer cell lines. While TBP had the lowest expression stability in the three hepatic cancer cell lines. Moreover, YWHAZ, UBC, and GAPDH showed the highest stability in breast cancer cell lines. Besides that, a panel of five nominees, including ACTB, HPRT1, UBC, YWHAZ, and B2M showed higher stability than others in hepatic cancer cell lines. We believe that our results would help researchers to find and to select the best combination of the reference genes for their own experiments involving the studied breast and hepatic cancer cell lines. To further analyze the reference genes stability for each experimental condition, we suggest researchers to consider the provided stability ranking emphasizing the unstable reference genes.

Citation: Gorji-Bahri G, Moradtabrizi N, Hashemi A (2021) Uncovering the stability status of the reputed reference genes in breast and hepatic cancer cell lines. PLoS ONE 16(11): e0259669. https://doi.org/10.1371/journal.pone.0259669

Editor: Xiaoping Pan, East Carolina University, UNITED STATES

Received: July 17, 2021; Accepted: October 22, 2021; Published: November 9, 2021

Copyright: © 2021 Gorji-Bahri et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the manuscript and its Supporting information files.

Funding: This work was supported by the research deputy of Shahid Beheshti University of Medical Sciences, Tehran, Iran under Grant IR.SBMU.PHARMACY.REC.1397.233. atieh hashemi received the grant The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

The last statistics of WHO have shown that breast and liver cancers are among the six most prevalent cancers in both sexes. Breast cancer is accounted for the deadliest cancer in women. Whilst in men, after lung cancer, liver cancer is listed as the most lethal cancer all around the world [1]. Owing to the high prevalence of cancer in the whole world, studies on gene expression fluctuations both for therapeutic and diagnostic purposes have received much attention from researchers [2, 3]. One of the most useful, sensitive, and rapid techniques to analyze and compare genes expression levels is relative gene expression analysis via RT-qPCR, in which the mRNA expression level of a target gene is normalized against the expression of one or more reference genes [4]. The reliability and accuracy of the results directly depend on the choice of the appropriate reference genes. A reference gene with the same expression level in samples subjected to various treatments or in different physiologic and pathologic conditions is considered as a stable reference gene [5, 6]. Moreover, to maximize the accuracy of RT-qPCR data normalization, it is suggested to select reference genes with a close expression level to the target gene [6]. However, stability analysis of the reference genes previously showed that various tissue types might express different levels of a specific reference gene [6, 7]. Therefore, it is critical to evaluate and discern stable reference genes for each tissue type separately to have reliable outcomes of the RT-qPCR method.

The utilization of various established cancer cell lines instead of the primary cells facilitates studying the molecular mechanisms of cancers. According to the primary source of immortalized cancer cell lines, each line would reflect the characteristics of a specific classification of a type of cancer and has a distinct gene expression profile. For example, breast cancer cell lines such as MCF7, MDA-MB-231, and SKBR3 fairly represent different classifications of this heterogeneous cancer. Among them, MCF7 and MDA-MB231 cell lines are both human epidermal growth factor receptor 2 (HER2) negative, while MDA-MB231 is estrogen receptor (ER) negative too. In contrast to MCF7, SKBR3 is HER2 positive and ER-negative [8]. Besides that, HepG2, a well-known hepatocellular carcinoma cell line, was extensively considered for genotoxicity studies [9]. Moreover, varied gene expression profiles have been reported for four hepatic cancer cell lines, namely Huh7, HepG2, Hep3B, and Huh6 [10].

Accordingly, relative gene expression analysis in cell lines of a specific type of cancer strongly requires knowledge about the stable reference genes in the studied cell lines. Many researches have determined stable reference genes in cell lines under different treatment or conditions, such as silver nanoparticles [11] and hypoxia [12], respectively. Based on our searches, we did not find a study that examined the reference genes’ stability in several cancer cell lines of a type of cancer. However, frequently utilized reference genes like glyceraldehyde-3-phosphate dehydrogenase (GAPDH), regardless of their stability analysis, have been repeatedly reported in the literature [13]. Thus, in this study, the stability of eight useful reference genes in two sets of cancer cell lines, including hepatic cancer cell lines (HepG2, PLC-PRF5, and Huh7) and breast cancer cell lines (MCF7, MDA-MB231, and SKBR3) was analyzed via four distinct algorithms (GeNorm, NormFinder, BestKeeper, and RefFinder), which allows us to compare the expression and stability ranking orders of reference genes between two types of cancer. Moreover, the stability ranking of these reference genes in both hepatic and breast cancer cell lines in a simultaneous manner is also reported. Undoubtedly, considering the results of our study will accelerate and facilitate the selection of suitable reference genes in studies focusing on hepatic and breast cancer cell lines, which provide reliable RT-qPCR analysis.

Materials and methods

Cell culture

Hepatic cancer cell lines including HepG2, Huh7, and PLC-PRF5, and breast cancer cell lines including MDA-MB231, MCF7, and SKBR3 were obtained and cultured as follows: HepG2, PLC-PRF5, MDA-MB231, MCF7, and SKBR3 were bought from Pasteur Institute of Iran and cultured in RPMI 1640 medium (Inoclon, Iran). Huh7 cell line was purchased from Royan Institute of Iran and cultured in DMEM high glucose medium (Inoclon, Iran). The medium of all six cell lines was supplemented with 10% FBS (Gibco, USA) and 1% penicillin/streptomycin (Biosera, France). Cells were kept up in a humidified incubator with 37 Ċ temperature and 5% CO2.

Selection of reference genes, designing the primer pairs, and calculation of PCR efficiency

Reference genes and corresponding primers used in this study were the same selected and designed in our previously published articles [11, 14–16]. Evidences considering the usage of these reference genes in hepatic and breast cancer cell lines are presented in Table 1; not exactly the cell lines investigated in this study. The specificity of primer pairs was checked via 1% agarose gel electrophoresis and melt curve analysis. The primer pairs spanned at least one intron or exon-exon junction, resulting in amplification of mRNA rather than genomic DNA.

Download:

Table 1. Properties of the designed primers of the eight nominee reference genes.

https://doi.org/10.1371/journal.pone.0259669.t001

PCR efficiency (E) was also provided using LinregPCR version 2017 software. Instead of making serial dilutions and drawing standard curves which may cause errors in PCR efficiency calculation due to common pipetting errors, the LinregPCR software calculates PCR efficiency for individual reaction via calculating the slope of the regression line in an exponential phase of the amplification curve, namely Window-of-Linearity (W-o-L) area, and reports the mean PCR efficiency of samples containing same primer pairs [14, 17]. Using the LinregPCR software, the imported raw amplification data of each RT-qPCR run, belong to each reference gene analysis was automatically corrected for baseline adjustment, and at least 3 points were incorporated for the W-o-L area of each sample. Finally, the mean PCR efficiencies were reported as a value between 1 and 2, in which the 2 value refers to 100% amplification efficiency. In comparison, the 1 value refers to no amplification. Only the mean PCR efficiency ± SD values in Table 1 are specific for this study. Sequences of primer pairs were already published by our team [11, 14–16].

Isolation of total RNA and synthesis of complementary DNA (cDNA)

Total RNA of each cell line was isolated individually using Trizol reagent (Invitrogen, USA) according to the manufacturer’s instruction with some modifications. Briefly, 80% confluent T25 flask, containing approximately 3 × 10⁶ cells were lysed via 1 ml Trizol reagent and incubated for 5 min at room temperature. Subsequently, 200 μl chloroform was added to the sample, shook vigorously for 15 sec, and incubated for 15 min at room temperature. After that, phase separation was performed via centrifugation at 12000 ×g for 15 min at 4 Ċ. The clear aqueous phase supernatant containing RNA was carefully separated from genomic DNA at the interphase, using 10 μl pipette tips. To precipitate RNA, 500 μl cold isopropanol was added to the sample and incubated for 10 min at -20 Ċ, followed by centrifugation at 12000 ×g for 10 min at 4 Ċ. The precipitated RNA was suspended in 1 ml 75% ethanol and centrifuged at 7500 ×g for 5 min at 4 Ċ. The RNA pellet was air-dried at room temperature and finally dissolved in 30 μl pre-warm (55 Ċ) ultrapure DEPC-treated water (Invitrogen, USA). Using 1% agarose gel electrophoresis, RNA28S/RNA18S band intensity ratio was checked, and the integrity of the extracted RNA was confirmed. The 260/280 absorbance ratio was also checked to confirm the purity of the isolated RNA (HTX multimode reader (BioTek)). Finally, the high-quality isolated RNA was quantified, stored at about -80 Ċ until use within six months.

Using cDNA synthesis kit (Yekta Tajhiz, Iran), cDNA synthesis was carried out as stated in the manufacturer’s instruction, in which total RNA of each cell line (1 μg), random hexamer primer (50 μM), and MMLV reverse transcriptase (200U/μl) along with dNTPs (10 mM), 5X first strand buffer and RNAse inhibitor (40 U/μl) were included in 20 μl volume reaction. The synthetized cDNA was stored at about -20 Ċ until use within two weeks.

RT-qPCR

Ten microliter volume reactions containing 5 μl SYBR premix Ex TaqII (2X) (Takara, Japan), 1 μl cDNA (equivalent to 50 ng RNA), 0.4 μl of forward and reverse primers (10 μM), 0.2 μl ROX reference dye (50X) and 3 μl distilled H₂O (water for injection) were placed in Step One Real-Time PCR system (Applied Biosystems, Singapore). Thermal cycles were set as the following program: primary denaturation at 95 Ċ for 30 sec and subsequently 40 cycles of polymerase chain reactions at 95 Ċ for 5 sec and 60 Ċ for 30 sec. All experiments encompassed two biological replicates of each cell line in triplicates. The mean of technical triplicates of each sample was used for statistical analysis. The NTC (no template control) was also incorporated in each run of RT-qPCR.

Reference genes stability analysis

The distribution of the quantification cycle (Cq) values was firstly analyzed. After that, the stability ranking of the nominee reference genes was computed using GeNorm, NormFinder, and RefFinder algorithms. The geNorm calculates M values in which the higher the M values, the lower the expression stability of the nominees. Besides that, pairwise variation analysis via the geNorm also exhibited the optimum number of reference genes needed for data normalization [6]. Excel-based Normfinder obtained from https://moma.dk/normfinder-software/normfinder-faq also evaluates the overall variation of nominees as well as the variation between subgroups. Similar to geNorm, a lower stability value indicates higher expression stability [31]. Another excel-based algorithm, namely BestKeeper, was downloaded from https://www.gene-quantification.de/bestkeeper.html. BestKeepr ranks reference genes via pairwise correlation analysis and calculation of the standard deviation (SD) and the coefficient of variance (CV), which results in higher stability of genes expression when they have lower variations [32]. RefFinder, which is accessible through https://www.heartcure.com.au/reffinder/?type=reference, calculates comprehensive ranking based on the geometric mean of weights in which the weights are assigned to the nominee ranks calculated by four algorithms comprising geNorm, normFinder, Delta Ct, and BestKeeper [33].

Results

Expression status of nominee reference genes in hepatic and breast cancer cell lines

To display the distribution of Cq values of nominee reference genes, initially, we checked the quality of the extracted RNA samples. As shown in Fig 1A, the integrity of RNA samples was confirmed through the 2:1 ratio of RNA28S/RNA18S band intensities on 1% agarose gel. Moreover, the range 1.9–2.1 of 260 to 280 nm absorbance ratio showed the purity of the extracted total RNAs. The high PCR efficiency (E), in the range of 1.9–2, calculated via LinregPCR software, indicated the high efficiency of the designed primers in PCR product amplification of the cellular RNA. The PCR efficiency (Mean PCR efficiency ± SD) of all nominee genes is presented in Table 1. A clear band of PCR products on 1% agarose gel electrophoresis (Fig 1B), as well as not seeing primer dimers in the related melt curves, proved the specificity of the designed primers. The efficiency and specificity of these primers except hypoxanthine phosphoribosyltransferase 1 (HPRT1), TATA-box binding protein (TBP), and actin beta (ACTB) were also studied in exosomal RNA of hepatic and breast cancer cell lines by our team recently [14]. However, here we confirmed their efficiency and specificity in cellular RNA of three hepatic and three breast cancer cell lines.

Download:

Fig 1. Expression of reference genes and Cq distribution in hepatic and breast cancer cell lines.

A. Integrity analysis of the isolated RNA derived from SKBR3 cell line. The 2:1 ratio of RNA28S/RNA18S band intensities on 1% agarose gel confirmed the integrity of the extracted RNA. Similar results were obtained for the other five cancer cell lines. B. Specificity analysis of the designed primers. Based on the results obtained from agarose gel electrophoresis, a single band of each gene’s RT-qPCR product at the anticipated size confirmed the specificity of the used primers. The isolated RNA sample (Fig 1A), cDNA template, and the RT-qPCR products (Fig 1B) belonged to the SKBR3 cell line. Full-length gels are presented in S1 Fig. C. Cq values distribution of the nominee reference genes in three hepatic cancer cell lines, three breast cancer cell lines, and their combination. The graph is provided as box and whiskers that the latter shows 10–90 percentile.

https://doi.org/10.1371/journal.pone.0259669.g001

Cq values distribution analysis (Fig 1C) also showed that in both hepatic and breast cancer cell lines, 18S ribosomal RNA (RNA18S) was the most expressed reference gene with the mean Cq ± SD equals to 12.7 ± 1.209 and 12.55 ± 1.994, respectively. While TBP (mean Cq ± SD = 29 ± 2.59) and HPRT1 (mean Cq ± SD = 25.36 ± 1.311) were the least abundant reference genes in hepatic and breast cancer cell lines, respectively. More details in Cq values distribution are presented in Table 2. In Table 2 and all graphs, the combined box or column refers to the statistical analysis of samples of six cancer cell lines in two biological replicates (n = 12). Each of these twelve Cq values is the mean of technical triplicates. Technical triplicates of each sample had differences lower than 0.1 Ct value. Accordingly, hepatic and breast boxes or columns contain Cq values derived from samples of three hepatic cancer cell lines (including two biological replicates for each cell line, n = 6) and three breast cancer cell lines (including two biological replicates for each cell line, n = 6), respectively.

Download:

Table 2. The Cq values of nominee reference genes in hepatic and breast cancer cell lines.

https://doi.org/10.1371/journal.pone.0259669.t002

Stability status analysis of nominee reference genes employing geNorm excel-based software

To have appropriate geNorm input data, the mean Cq values of all samples for each reference gene were first transformed to quantities using PCR efficiency (E) according to the geNorm manual. As shown in Fig 2A and Table 3, in HepG2, Huh7, and PLC-PRF5 cell lines, ACTB and beta-2-microglobulin (B2M) had the lowest M values (0.477). Thereby, ACTB and B2M are classified as the most stable reference genes equally followed by HPRT1, tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ), ubiquitin C (UBC), and RNA18S, respectively. In MCF7, SKBR3, and MDA-MB-231 cell lines, YWHAZ and UBC had the least M values (0.222) and the highest stability ranking order. After that, GAPDH, HPRT1, RNA18S, and TBP were the most stable ones, respectively. However, GAPDH and TBP in hepatic cancer cell lines and ACTB and B2M in breast cancer cell lines have M values > 1, which causes us to consider them as unstable reference genes.

Download:

Fig 2.

Stability ranking orders of the studied reference genes resulted from A. geNorm, B. NormFinder, and C. RefFinder algorithms in the combined sample besides the hepatic and breast cancer cell lines separately. D. Indication of the optimum number of reference genes in the combined sample besides the breast and hepatic cancer cell lines separately via geNorm algorithm. The combined sample refers to hepatic and breast cancer cells together.

https://doi.org/10.1371/journal.pone.0259669.g002

Download:

Table 3. Stability ranking order of nominee reference genes determined by GeNorm algorithm.

https://doi.org/10.1371/journal.pone.0259669.t003

Furthermore, when we analyzed both samples together, geNorm ranked YWHAZ, UBC, HPRT1, and RNA18S as the most stable nominees, respectively. Whereas GAPDH, ACTB, B2M, and TBP were ranked as the least stable ones.

Stability status analysis of nominee reference genes employing NormFinder excel-based software

To provide NormFinder input data, the mean Cq values of all samples for each reference gene were transformed to the linear scale expression quantities according to the producer’s instruction. The lowest expression stability value exhibits the most stable reference gene. As shown in Fig 2B and Table 4, in hepatic cancer cell lines, B2M, GAPDH, UBC, and HPRT1 were the first four stable nominees, respectively, and RNA18S was determined as the least stable ones. In breast cancer cell lines, GAPDH, TBP, and UBC were the most stable reference genes almost equally. While similar to geNorm, ACTB and B2M were the least stable ones in breast cancer cell lines. In the combined condition, UBC, HPRT1, and B2M were the first three stable reference genes, respectively. However, UBC and RNA18S were ranked as the best combination of two reference genes for data normalization (Stability value = 0.062). Moreover, ACTB and GAPDH were determined as the least stable ones almost equally.

Download:

Table 4. Stability ranking order of nominee reference genes determined by NormFinder algorithm.

https://doi.org/10.1371/journal.pone.0259669.t004

Stability status analysis of nominee reference genes employing BestKeeper excel-based software

To rank the reference genes stability, analysis by BestKeepr excel based algorithm was also performed. Our analysis showed that in the combined condition, all genes had a standard deviation ± crossing point (SD ± CP) > 1. While reference genes with SD>1 are considered inconsistent by BestKeeper [32]. In contrast to NormFinder output, BestKeeper analysis showed RNA18S as the only reference gene with SD<1 (0.98) in hepatic cancer cell lines. In breast cancer cells, similar to geNorm and NormFinder that ranked HPRT1 as the first five stable reference genes, BestKeeper also indicated HPRT1 as the only nominee with SD<1 (0.85). The BestKeeper outputs for hepatic and breast cancer cell lines are presented in Table 5. Moreover, similar to the geNorm output, TBP, and GAPDH for hepatic cancer cell lines and B2M for breast cancer cell lines were sorted as the least stable reference genes.

Download:

Table 5. Stability ranking order of nominee reference genes determined by BestKeeper algorithm.

https://doi.org/10.1371/journal.pone.0259669.t005

Stability status analysis of nominee reference genes employing RefFinder tool

Finally, we analyzed the overall ranking of all nominees employing the RefFinder online tool. The mean Cq values were entered into the input area of the webpage. The overall ranking orders derived from the RefFinder algorithm are presented in Fig 2C and Table 6. Similar to the geNorm and NormFinder algorithms, UBC was graded as the most stable reference genes in the combined condition. Moreover, B2M and TBP were indicated as the least stable ones, similar to the results of the geNorm algorithm. In hepatic cancer cell lines, the first six stable reference genes were YWHAZ, ACTB, B2M, UBC, HPRT1, and RNA18S. TBP and GAPDH were also showed the lowest expression stability. Slightly different ranking orders of these genes were displayed by the geNorm algorithm. In breast cancer cell lines, exactly the same ranking order as the geNorm algorithm was reported in which UBC and B2M were the most and the least stable genes, respectively.

Download:

Table 6. Stability ranking order of nominee reference genes determined by RefFinder algorithm.

https://doi.org/10.1371/journal.pone.0259669.t006

The optimum number of reference genes for reliable normalization of RT-qPCR

Assessing the pairwise variation through the geNorm software was carried out to find the optimum number of reference genes for each sample type. Based on the report of Vandesompele et al., 0.15 V value is usually considered as a cut-off point which means that if V_n/V_n+1 was lower than 0.15, the addition of another reference gene is not needed for RT-qPCR data normalization [6]. As shown in Fig 2D, V₂/V₃ for breast cancer cell lines was 0.111, which pointed out that utilization of the first two stable reference genes is adequate for RT-qPCR data normalization in the three studied breast cancer cell lines. Although 0.15 is usually considered as a cut-off value, the 0.15 value is not a strict cut-off point. Indeed, with the lowest V_n/V_n+1 value, the “n” presents the optimum number of reference genes. Accordingly, our results showed that the first five stable reference genes are required for reliable data normalization when studying target gene expression in Huh7, HepG2, and PLC-PRF5 cell lines. Also, V₄/V₅ equals 0.202 indicated that the use of at least four reference genes for the correct normalization of RT-qPCR data has been proposed by geNorm when both hepatic and breast cancer cell lines are studied together.

Discussion

Gene expression analysis using RNA-sequencing; a high throughput technique, and an older DNA hybridization method; microarray, allows studying the expression of a large number or even the whole transcriptome simultaneously, which have received great successes in discovering the pathological pathways of diseases, especially cancer and diagnosis and prognosis biomarkers [34–37]. However, their high cost is limiting for many laboratories [38]. RT-qPCR is a powerful, rapid, inexpensive, highly accessible, always applicable and accurate method in relative mRNA expression analysis, which is often employed for validation of RNA-seq or microarray results [35, 39]. Moreover, it can also be used alone for relative gene expression analysis of an approximately limited number of genes compared with the RNA-seq method [40]. However, the accuracy of its results strongly relies on the selection of stable reference genes to normalize the data [41]. Since it has been shown that different tissues have different gene expression profiles [6], it is important to uncover and introduce stable reference genes in each tissue type. Today, cancer cell lines are widely used and available for researchers as an accessible sample of a specific cancer type [8]. However, some cell lines may not fully reflect the characteristics of the original tissue [42].

Many published research articles have utilized reference genes to normalize RT-qPCR data without analyzing their stability in the specific condition of that experiment and have chosen them only based on their previous usage or their reputation [43]. Therefore, we decided to evaluate the stability of eight well-known reference genes in three breast and three hepatic cancer cell lines using four algorithms, namely geNorm, NormFinder, BestKeeper, and RefFinder.

Our results overally indicated that GAPDH, YWHAZ, and UBC were the most stable reference genes in breast cancer cell lines, including MCF7, SKBR3 and MDA-MB231, and B2M and ACTB were the least stable ones. Moreover, in hepatic cancer cell lines including Huh7, HepG2, and PLC-PRF5, ACTB, HPRT1, UBC, B2M, and YWHAZ were among the first six stable genes ranked by geNorm, NormFinder, and RefFinder algorithm. While TBP was ranked among the unstable reference genes in the studied three hepatic cancer cell lines.

We have recently reported the expression and stability status of reference genes for exosomal content of the same hepatic cancer cell lines as this study and SKBR3 as breast cancer cell line [14]. Interestingly, the geNorm showed almost similar stability ranking for cellular and exosomal content, in which B2M and YWHAZ were ranked as two stable reference genes (M value < 1) in Huh7, HepG2, and PLC-PRF5 cell lines. Similarly, YWHAZ was also classified by the RefFinder as the most stable reference gene in the cellular and exosomal content of hepatic cancer cell lines. Regarding the combination of hepatic and breast cancer cell lines, the geNorm indicated UBC as the most stable reference gene, and the RefFinder ranked UBC and YWHAZ as two stable ones in both cellular and exosomal content. Although based on two algorithms, the stability ranking of few reference genes in cellular and exosomal content was similar, other algorithms showed various ranking orders, emphasizing the importance of stability analysis for each experimental condition.

It has been stated that YWHAZ and UBC were ranked as the most stable reference genes by geNorm and NormFinder when the three cell lines, namely MCF7, HCT116, and HepG2, were studied simultaneously. However, the authors did not analyze the cell lines individually [23]. In another study, YWHAZ, along with H2A clustered histone 13 (HIST), showed the lowest stability values of geNorm and NormFinder in apoptosis induced-MCF7 cell line, which suggested their usage as RT-qPCR data normalizer in the studied experimental condition. Though this study reported GAPDH as the least stable nominee among the other four reference genes including YWHAZ, HIST, ACTB, and heat shock protein family A (Hsp70) member 8 (HSC70), more detailed reviewing of the results showed that the stability values (M) derived from the geNorm algorithm were lower than 0.6 for all five reference genes [44]. Moreover, in a study by McNeill et al., among eleven nominee reference genes in breast cancer tissue, GAPDH was categorized as the fourth stable gene via the geNorm algorithm that was more stable than HPRT1 and B2M [45]. Nevertheless, existing evidence indicates that the expression of GAPDH in breast cancer tissues or cell lines would be changed under different pathological conditions or experimental treatments. For example, the association of GAPDH expression with the aggressiveness of breast cancer and its upregulation in oestradiol treated MCF7 cells [46] or its downregulation in amino-bisphosphonate treated MCF7 and T47D cell lines [47].

Besides that, analyzing the stability of reference genes in breast cancer tissues by Kilic et al. has shown the instability of ACTB and B2M in which the M values derived from the geNorm algorithm were higher than 1.5 [48]. In a similar study designed by Majidzadeh et al., although ACTB and transferrin receptor (TFRC) had the lowest M values of the geNorm software, even the lowest M value was higher than 1.5, indicating their instability in breast cancer tissues [49]. Our previous study regarding stability analysis of reference genes in RAB5A-knocked down Huh7 cells via five different algorithms determined that ACTB and HPRT1 had the highest stability grade among the other six reference genes. While TBP showed the opposite stability status [15]. Moreover, another study showed that in interferon-alpha treated Huh7 and HepG2 cells, a combination of GAPDH and HPRT1 had the lowest stability value of the geNorm algorithm. The NormFinder also showed HPRT1 as the most stable genes. TBP was also ranked as the least stable gene using both algorithms [50].

Although here we also ranked reference genes in a combined manner of both breast and hepatic cancer cell lines, due to the Cq variations between different tissues, it is not recommended to use the same genes for both tissue types unless the reference genes stability is analyzed under the specific situation of the experiment.

Conclusion

According to the obtained results, to normalize RT-qPCR data of MCF7, SKBR3, and MDA-B231 cell lines reliably, it is recommended to use YWHAZ, UBC, and GAPDH as reference genes or further evaluate their expression stability in a specific experiment involving the above three cell lines. Similarly, a panel of five reference genes, namely ACTB, HPRT1, UBC, YWHAZ, and B2M is also recommended for RT-qPCR data normalization of three hepatic cancer cell lines, including Huh7, HepG2, and PLC-PRF5. Moreover, for the studied cell lines, it is proposed that not to use ACTB and B2M; and TBP for normalizing the breast and hepatic cancer cell lines derived RT-qPCR data, respectively. Since cells experimental conditions like passage number and different treatments can change the stability ranking orders of reference genes [51, 52], considering the stability and instability status of the eight reference genes via four algorithms provided in this study, would initially help to find the most stable RT-qPCR data normalizers of breast and hepatic cancer cell lines.

Supporting information

S1 Fig. Uncropped and unprocessed images of 1% agarose gel electrophoresis with the indicated areas that are presented in Fig 1a and 1b of the article.

A. Integrity analysis of the isolated RNA samples derived from SKBR3 cell line. B. Primer specificity analysis of PCR products. The isolated RNA sample (S1A Fig), cDNA template, and the RT-qPCR products (S1B Fig) belonged to the SKBR3 cell line.

https://doi.org/10.1371/journal.pone.0259669.s001

(PDF)

References

1. Cancer Today: World Health Organization; 2020 [cited 2021 25 Apr]. https://gco.iarc.fr/today/.
2. Hassan N, Rutsch N, Győrffy B, Espinoza-Sánchez NA, Götte M. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. Sci Rep. 2020;10(1), pmid:32042016
- View Article
- PubMed/NCBI
- Google Scholar
3. Su H-C, Wu S-C, Yen L-C, Chiao L-K, Wang J-K, Chiu Y-L, et al. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis. Sci Rep. 2020;10(1), pmid:32678267
- View Article
- PubMed/NCBI
- Google Scholar
4. Lee S, Hallis SP, Jung K-A, Ryu D, Kwak M-K. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells. Redox Biol. 2019;24:101210. pmid:31078780
- View Article
- PubMed/NCBI
- Google Scholar
5. Hernandez-Segura A, Rubingh R, Demaria M. Identification of stable senescence-associated reference genes. Aging Cell. 2019;18(2):e12911. pmid:30710410
- View Article
- PubMed/NCBI
- Google Scholar
6. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):research0034.1. pmid:12184808
- View Article
- PubMed/NCBI
- Google Scholar
7. Cabiati M, Raucci S, Caselli C, Guzzardi MA, D’Amico A, Prescimone T, et al. Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model. J Mol Endocrinol. 2012;48(3):251. pmid:22493144
- View Article
- PubMed/NCBI
- Google Scholar
8. Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13(4):1–7. pmid:21884641
- View Article
- PubMed/NCBI
- Google Scholar
9. Shah U-K, de Oliveira Mallia J, Singh N, Chapman KE, Doak SH, Jenkins GJ. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutat Res Genet Toxicol Environ Mutagen. 2018;825:51–8. pmid:29307375
- View Article
- PubMed/NCBI
- Google Scholar
10. Berardocco M, Radeghieri A, Busatto S, Gallorini M, Raggi C, Gissi C, et al. RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines. Oncotarget. 2017;8(47):82920–39. pmid:29137313
- View Article
- PubMed/NCBI
- Google Scholar
11. Pourani Z, Hashemi A. Stability assessment of reference genes for reliable analysis of silver nanoparticles cytotoxicity in HepG2 cell line. Journal of Cluster Science. 2017;28(5):2623–34.
- View Article
- Google Scholar
12. Yan W, Xie M, Li R, Hu H, Tang B, Shen J. Identification and Validation of Reference Genes Selection in Ovarian Cancer Exposed to Hypoxia. Onco Targets Ther. 2020;13:7423–31. pmid:32801765
- View Article
- PubMed/NCBI
- Google Scholar
13. Wang Y, Zhou J, Wang Z, Wang P, Li S. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion. Biochem Biophys Res Commun. 2017;493(1):429–36. pmid:28882595
- View Article
- PubMed/NCBI
- Google Scholar
14. Gorji-Bahri G, Moradtabrizi N, Vakhshiteh F, Hashemi A. Validation of common reference genes stability in exosomal mRNA-isolated from liver and breast cancer cell lines. Cell Biol Int. 2021, 45(5):1098–1110. pmid:33501690
- View Article
- PubMed/NCBI
- Google Scholar
15. Gorji-bahri G, Moghimi HR, Hashemi A. RAB5A is associated with genes involved in exosome secretion: Integration of bioinformatics analysis and experimental validation. J Cell Biochem. 2020. 122(3–4):425–441. pmid:33225526
- View Article
- PubMed/NCBI
- Google Scholar
16. Karimi Z., Hashemi A. Validation of Reference Genes for Silver Nanotoxicity Analysis in MCF-7 Cell Line. Journal of Cluster Science. 2018, 29, 159–66.
- View Article
- Google Scholar
17. Rueda-Martínez C, Lamas O, Mataró M J, Robledo-Carmona J, Sánchez-Espín G, Jiménez-Navarro M, et al. Selection of reference genes for quantitative real time PCR (qPCR) assays in tissue from human ascending aorta. PloS One. 2014; 9(5), e97449. pmid:24841551
- View Article
- PubMed/NCBI
- Google Scholar
18. Leng E, Xiao Y, Mo Z, Li Y, Zhang Y, Deng X, et al. Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells. BMC Complement Altern Med. 2018;18(1). pmid:29622007
- View Article
- PubMed/NCBI
- Google Scholar
19. Alotaibi MR, Hassan ZK, Al-Rejaie SS, Alshammari MA, Almutairi MM, Alhoshani AR, et al. Characterization of apoptosis in a breast cancer cell line after IL-10 silencing. Asian Pac J Cancer Prev. 2018;19(3):777–83. pmid:29582634
- View Article
- PubMed/NCBI
- Google Scholar
20. Vydra N, Janus P, Toma-Jonik A, Stokowy T, Mrowiec K, Korfanty J, et al. 17β-estradiol activates HSF1 via MAPK signaling in ERα-positive breast cancer cells. Cancers (Basel). 2019;11(10):1533. pmid:31614463
- View Article
- PubMed/NCBI
- Google Scholar
21. Gómez V, Eykyn TR, Mustapha R, Flores-Borja F, Male V, Barber PR, et al. Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Sci Signal. 2020;13(652). pmid:33023985
- View Article
- PubMed/NCBI
- Google Scholar
22. Marin D, Pistol G, Bulgaru C, Taranu I. Cytotoxic and inflammatory effects of individual and combined exposure of HepG2 cells to zearalenone and its metabolites. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(8):937–47. pmid:30919009
- View Article
- PubMed/NCBI
- Google Scholar
23. Chua SL, Too WCS, Khoo BY, Few LL. UBC and YWHAZ as suitable reference genes for accurate normalisation of gene expression using MCF7, HCT116 and HepG2 cell lines. Cytotechnology. 2011;63(6):645–54. pmid:21850463
- View Article
- PubMed/NCBI
- Google Scholar
24. Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, et al. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling. Oncogene. 2018;37(34):4723–34. pmid:29760406
- View Article
- PubMed/NCBI
- Google Scholar
25. Zhang G, Tang X, Liang L, Zhang W, Li D, Li X, et al. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene. 2020;39(16):3229–44. pmid:32071398
- View Article
- PubMed/NCBI
- Google Scholar
26. Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, et al. Peroxisome proliferator–activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog. 2002;34(4):165–71. pmid:12203367
- View Article
- PubMed/NCBI
- Google Scholar
27. Wu W-Y, Li J, Wu Z-S, Zhang C-L, Meng X-L. STAT3 activation in monocytes accelerates liver cancer progression. BMC Cancer. 2011;11. pmid:22136659
- View Article
- PubMed/NCBI
- Google Scholar
28. Huang P-S, Lin Y-H, Chi H-C, Tseng Y-H, Chen CY, Lin T-K, et al. Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer. Cells. 2020;9(4):961. pmid:32295144
- View Article
- PubMed/NCBI
- Google Scholar
29. Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39(23):4507–18. pmid:32366907
- View Article
- PubMed/NCBI
- Google Scholar
30. Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–70. pmid:29171881
- View Article
- PubMed/NCBI
- Google Scholar
31. Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–50. pmid:15289330
- View Article
- PubMed/NCBI
- Google Scholar
32. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper–Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26(6):509–15. pmid:15127793
- View Article
- PubMed/NCBI
- Google Scholar
33. Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol. 2012;80(1):75–84. pmid:22290409
- View Article
- PubMed/NCBI
- Google Scholar
34. Costa-Silva J, Domingues D, Lopes FM. RNA-Seq differential expression analysis: An extended review and a software tool. PloS One. 2017;12(12):e0190152. pmid:29267363
- View Article
- PubMed/NCBI
- Google Scholar
35. Maltseva DV, Khaustova NA, Fedotov NN, Matveeva EO, Lebedev AE, Shkurnikov MU, et al. High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples. J Clin Bioinforma. 2013;3(1):13. pmid:23876162
- View Article
- PubMed/NCBI
- Google Scholar
36. Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A. A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Scientific Rep 2018;8(1):575. pmid:29330370
- View Article
- PubMed/NCBI
- Google Scholar
37. Wang J, Dean DC, Hornicek FJ, Shi H, Duan Z. RNA sequencing (RNA-Seq) and its application in ovarian cancer. Gynecol Oncol. 2019;152(1):194–201. pmid:30297273
- View Article
- PubMed/NCBI
- Google Scholar
38. Whitley SK, Horne WT, Kolls JK. Research techniques made simple: methodology and clinical applications of RNA sequencing. J Invest Dermatol. 2016;136(8):e77–e82. pmid:27450500
- View Article
- PubMed/NCBI
- Google Scholar
39. Rajeevan MS, Vernon SD, Taysavang N, Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn. 2001;3(1):26–31. pmid:11227069
- View Article
- PubMed/NCBI
- Google Scholar
40. Nourbakhsh N, Emadi-Baygi M, Salehi R, Nikpour P. Gene expression analysis of two epithelial-mesenchymal transition-related genes: Long noncoding RNA-ATB and SETD8 in gastric cancer tissues. Adv Biomed Res. 2018;7. pmid:29657927
- View Article
- PubMed/NCBI
- Google Scholar
41. Hellemans J, Vandesompele J. Selection of reliable reference genes for RT-qPCR analysis. Methods Mol Biol. 2014. 1160:19–26. pmid:24740218
- View Article
- PubMed/NCBI
- Google Scholar
42. Nwosu ZC, Battello N, Rothley M, Piorońska W, Sitek B, Ebert MP, et al. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. J Exp Clin Cancer Res. 2018;37(1):211. pmid:30176945
- View Article
- PubMed/NCBI
- Google Scholar
43. Li T, Zhu J, Wang X, Chen G, Sun L, Zuo S, et al. Long non‑coding RNA lncTCF7 activates the Wnt/β‑catenin pathway to promote metastasis and invasion in colorectal cancer. Oncol Lett. 2017;14(6):7384–90. pmid:29344178
- View Article
- PubMed/NCBI
- Google Scholar
44. Ferreira E, Cronjé MJ. Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells. Mol Biotechnol. 2012;50(2):121–8. pmid:21681549
- View Article
- PubMed/NCBI
- Google Scholar
45. McNeill RE, Miller N, Kerin MJ. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol. 2007;8:107. pmid:18042273
- View Article
- PubMed/NCBI
- Google Scholar
46. Revillion F, Pawlowski V, Hornez L, Peyrat J-P. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer. 2000;36(8):1038–42. pmid:10885609
- View Article
- PubMed/NCBI
- Google Scholar
47. Valenti MT, Bertoldo F, Dalle Carbonare L, Azzarello G, Zenari S, Zanatta M, et al. The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? BMC Cancer. 2006;6:49. pmid:16515701
- View Article
- PubMed/NCBI
- Google Scholar
48. Kılıç Y, Celebiler A, Sakızlı M. Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer. Clin Transl Oncol. 2014;16(2):184–90. pmid:23720140
- View Article
- PubMed/NCBI
- Google Scholar
49. Majidzadeh-A K, Esmaeili R, Abdoli N. TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer. BMC Res Notes. 2011;4:215. pmid:21702980
- View Article
- PubMed/NCBI
- Google Scholar
50. Hashemi A, Roohvand F, Ghahremani M-H. Selection of valid reference genes for expression studies of hepatic cell lines under IFN-α treatment. Biochem Biophys Res Commun. 2012;426(4):649–53. pmid:22982679
- View Article
- PubMed/NCBI
- Google Scholar
51. Jain N, Nitisa D, Pirsko V, Cakstina I. Selecting suitable reference genes for qPCR normalization: a comprehensive analysis in MCF-7 breast cancer cell line. BMC Mol Cell Biol. 2020;21(1):68. pmid:32977762
- View Article
- PubMed/NCBI
- Google Scholar
52. Liu L-L, Zhao H, Ma T-F, Ge F, Chen C-S, Zhang Y-P. Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection. PloS One. 2015;10(1):e0117058. pmid:25617865
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Cancer Today: World Health Organization; 2020 [cited 2021 25 Apr]. https://gco.iarc.fr/today/.

[ref2] 2. Hassan N, Rutsch N, Győrffy B, Espinoza-Sánchez NA, Götte M. SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells. Sci Rep. 2020;10(1), pmid:32042016
View Article
PubMed/NCBI
Google Scholar

[3] View Article

[4] PubMed/NCBI

[5] Google Scholar

[ref3] 3. Su H-C, Wu S-C, Yen L-C, Chiao L-K, Wang J-K, Chiu Y-L, et al. Gene expression profiling identifies the role of Zac1 in cervical cancer metastasis. Sci Rep. 2020;10(1), pmid:32678267
View Article
PubMed/NCBI
Google Scholar

[7] View Article

[8] PubMed/NCBI

[9] Google Scholar

[ref4] 4. Lee S, Hallis SP, Jung K-A, Ryu D, Kwak M-K. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells. Redox Biol. 2019;24:101210. pmid:31078780
View Article
PubMed/NCBI
Google Scholar

[11] View Article

[12] PubMed/NCBI

[13] Google Scholar

[ref5] 5. Hernandez-Segura A, Rubingh R, Demaria M. Identification of stable senescence-associated reference genes. Aging Cell. 2019;18(2):e12911. pmid:30710410
View Article
PubMed/NCBI
Google Scholar

[15] View Article

[16] PubMed/NCBI

[17] Google Scholar

[ref6] 6. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):research0034.1. pmid:12184808
View Article
PubMed/NCBI
Google Scholar

[19] View Article

[20] PubMed/NCBI

[21] Google Scholar

[ref7] 7. Cabiati M, Raucci S, Caselli C, Guzzardi MA, D’Amico A, Prescimone T, et al. Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model. J Mol Endocrinol. 2012;48(3):251. pmid:22493144
View Article
PubMed/NCBI
Google Scholar

[23] View Article

[24] PubMed/NCBI

[25] Google Scholar

[ref8] 8. Holliday DL, Speirs V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 2011;13(4):1–7. pmid:21884641
View Article
PubMed/NCBI
Google Scholar

[27] View Article

[28] PubMed/NCBI

[29] Google Scholar

[ref9] 9. Shah U-K, de Oliveira Mallia J, Singh N, Chapman KE, Doak SH, Jenkins GJ. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutat Res Genet Toxicol Environ Mutagen. 2018;825:51–8. pmid:29307375
View Article
PubMed/NCBI
Google Scholar

[31] View Article

[32] PubMed/NCBI

[33] Google Scholar

[ref10] 10. Berardocco M, Radeghieri A, Busatto S, Gallorini M, Raggi C, Gissi C, et al. RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines. Oncotarget. 2017;8(47):82920–39. pmid:29137313
View Article
PubMed/NCBI
Google Scholar

[35] View Article

[36] PubMed/NCBI

[37] Google Scholar

[ref11] 11. Pourani Z, Hashemi A. Stability assessment of reference genes for reliable analysis of silver nanoparticles cytotoxicity in HepG2 cell line. Journal of Cluster Science. 2017;28(5):2623–34.
View Article
Google Scholar

[39] View Article

[40] Google Scholar

[ref12] 12. Yan W, Xie M, Li R, Hu H, Tang B, Shen J. Identification and Validation of Reference Genes Selection in Ovarian Cancer Exposed to Hypoxia. Onco Targets Ther. 2020;13:7423–31. pmid:32801765
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref13] 13. Wang Y, Zhou J, Wang Z, Wang P, Li S. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion. Biochem Biophys Res Commun. 2017;493(1):429–36. pmid:28882595
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref14] 14. Gorji-Bahri G, Moradtabrizi N, Vakhshiteh F, Hashemi A. Validation of common reference genes stability in exosomal mRNA-isolated from liver and breast cancer cell lines. Cell Biol Int. 2021, 45(5):1098–1110. pmid:33501690
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref15] 15. Gorji-bahri G, Moghimi HR, Hashemi A. RAB5A is associated with genes involved in exosome secretion: Integration of bioinformatics analysis and experimental validation. J Cell Biochem. 2020. 122(3–4):425–441. pmid:33225526
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref16] 16. Karimi Z., Hashemi A. Validation of Reference Genes for Silver Nanotoxicity Analysis in MCF-7 Cell Line. Journal of Cluster Science. 2018, 29, 159–66.
View Article
Google Scholar

[58] View Article

[59] Google Scholar

[ref17] 17. Rueda-Martínez C, Lamas O, Mataró M J, Robledo-Carmona J, Sánchez-Espín G, Jiménez-Navarro M, et al. Selection of reference genes for quantitative real time PCR (qPCR) assays in tissue from human ascending aorta. PloS One. 2014; 9(5), e97449. pmid:24841551
View Article
PubMed/NCBI
Google Scholar

[61] View Article

[62] PubMed/NCBI

[63] Google Scholar

[ref18] 18. Leng E, Xiao Y, Mo Z, Li Y, Zhang Y, Deng X, et al. Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells. BMC Complement Altern Med. 2018;18(1). pmid:29622007
View Article
PubMed/NCBI
Google Scholar

[65] View Article

[66] PubMed/NCBI

[67] Google Scholar

[ref19] 19. Alotaibi MR, Hassan ZK, Al-Rejaie SS, Alshammari MA, Almutairi MM, Alhoshani AR, et al. Characterization of apoptosis in a breast cancer cell line after IL-10 silencing. Asian Pac J Cancer Prev. 2018;19(3):777–83. pmid:29582634
View Article
PubMed/NCBI
Google Scholar

[69] View Article

[70] PubMed/NCBI

[71] Google Scholar

[ref20] 20. Vydra N, Janus P, Toma-Jonik A, Stokowy T, Mrowiec K, Korfanty J, et al. 17β-estradiol activates HSF1 via MAPK signaling in ERα-positive breast cancer cells. Cancers (Basel). 2019;11(10):1533. pmid:31614463
View Article
PubMed/NCBI
Google Scholar

[73] View Article

[74] PubMed/NCBI

[75] Google Scholar

[ref21] 21. Gómez V, Eykyn TR, Mustapha R, Flores-Borja F, Male V, Barber PR, et al. Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells. Sci Signal. 2020;13(652). pmid:33023985
View Article
PubMed/NCBI
Google Scholar

[77] View Article

[78] PubMed/NCBI

[79] Google Scholar

[ref22] 22. Marin D, Pistol G, Bulgaru C, Taranu I. Cytotoxic and inflammatory effects of individual and combined exposure of HepG2 cells to zearalenone and its metabolites. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(8):937–47. pmid:30919009
View Article
PubMed/NCBI
Google Scholar

[81] View Article

[82] PubMed/NCBI

[83] Google Scholar

[ref23] 23. Chua SL, Too WCS, Khoo BY, Few LL. UBC and YWHAZ as suitable reference genes for accurate normalisation of gene expression using MCF7, HCT116 and HepG2 cell lines. Cytotechnology. 2011;63(6):645–54. pmid:21850463
View Article
PubMed/NCBI
Google Scholar

[85] View Article

[86] PubMed/NCBI

[87] Google Scholar

[ref24] 24. Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, et al. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling. Oncogene. 2018;37(34):4723–34. pmid:29760406
View Article
PubMed/NCBI
Google Scholar

[89] View Article

[90] PubMed/NCBI

[91] Google Scholar

[ref25] 25. Zhang G, Tang X, Liang L, Zhang W, Li D, Li X, et al. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene. 2020;39(16):3229–44. pmid:32071398
View Article
PubMed/NCBI
Google Scholar

[93] View Article

[94] PubMed/NCBI

[95] Google Scholar

[ref26] 26. Suchanek KM, May FJ, Robinson JA, Lee WJ, Holman NA, Monteith GR, et al. Peroxisome proliferator–activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog. 2002;34(4):165–71. pmid:12203367
View Article
PubMed/NCBI
Google Scholar

[97] View Article

[98] PubMed/NCBI

[99] Google Scholar

[ref27] 27. Wu W-Y, Li J, Wu Z-S, Zhang C-L, Meng X-L. STAT3 activation in monocytes accelerates liver cancer progression. BMC Cancer. 2011;11. pmid:22136659
View Article
PubMed/NCBI
Google Scholar

[101] View Article

[102] PubMed/NCBI

[103] Google Scholar

[ref28] 28. Huang P-S, Lin Y-H, Chi H-C, Tseng Y-H, Chen CY, Lin T-K, et al. Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer. Cells. 2020;9(4):961. pmid:32295144
View Article
PubMed/NCBI
Google Scholar

[105] View Article

[106] PubMed/NCBI

[107] Google Scholar

[ref29] 29. Zhang C, Huang S, Zhuang H, Ruan S, Zhou Z, Huang K, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39(23):4507–18. pmid:32366907
View Article
PubMed/NCBI
Google Scholar

[109] View Article

[110] PubMed/NCBI

[111] Google Scholar

[ref30] 30. Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–70. pmid:29171881
View Article
PubMed/NCBI
Google Scholar

[113] View Article

[114] PubMed/NCBI

[115] Google Scholar

[ref31] 31. Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–50. pmid:15289330
View Article
PubMed/NCBI
Google Scholar

[117] View Article

[118] PubMed/NCBI

[119] Google Scholar

[ref32] 32. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper–Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004;26(6):509–15. pmid:15127793
View Article
PubMed/NCBI
Google Scholar

[121] View Article

[122] PubMed/NCBI

[123] Google Scholar

[ref33] 33. Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol. 2012;80(1):75–84. pmid:22290409
View Article
PubMed/NCBI
Google Scholar

[125] View Article

[126] PubMed/NCBI

[127] Google Scholar

[ref34] 34. Costa-Silva J, Domingues D, Lopes FM. RNA-Seq differential expression analysis: An extended review and a software tool. PloS One. 2017;12(12):e0190152. pmid:29267363
View Article
PubMed/NCBI
Google Scholar

[129] View Article

[130] PubMed/NCBI

[131] Google Scholar

[ref35] 35. Maltseva DV, Khaustova NA, Fedotov NN, Matveeva EO, Lebedev AE, Shkurnikov MU, et al. High-throughput identification of reference genes for research and clinical RT-qPCR analysis of breast cancer samples. J Clin Bioinforma. 2013;3(1):13. pmid:23876162
View Article
PubMed/NCBI
Google Scholar

[133] View Article

[134] PubMed/NCBI

[135] Google Scholar

[ref36] 36. Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A. A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Scientific Rep 2018;8(1):575. pmid:29330370
View Article
PubMed/NCBI
Google Scholar

[137] View Article

[138] PubMed/NCBI

[139] Google Scholar

[ref37] 37. Wang J, Dean DC, Hornicek FJ, Shi H, Duan Z. RNA sequencing (RNA-Seq) and its application in ovarian cancer. Gynecol Oncol. 2019;152(1):194–201. pmid:30297273
View Article
PubMed/NCBI
Google Scholar

[141] View Article

[142] PubMed/NCBI

[143] Google Scholar

[ref38] 38. Whitley SK, Horne WT, Kolls JK. Research techniques made simple: methodology and clinical applications of RNA sequencing. J Invest Dermatol. 2016;136(8):e77–e82. pmid:27450500
View Article
PubMed/NCBI
Google Scholar

[145] View Article

[146] PubMed/NCBI

[147] Google Scholar

[ref39] 39. Rajeevan MS, Vernon SD, Taysavang N, Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn. 2001;3(1):26–31. pmid:11227069
View Article
PubMed/NCBI
Google Scholar

[149] View Article

[150] PubMed/NCBI

[151] Google Scholar

[ref40] 40. Nourbakhsh N, Emadi-Baygi M, Salehi R, Nikpour P. Gene expression analysis of two epithelial-mesenchymal transition-related genes: Long noncoding RNA-ATB and SETD8 in gastric cancer tissues. Adv Biomed Res. 2018;7. pmid:29657927
View Article
PubMed/NCBI
Google Scholar

[153] View Article

[154] PubMed/NCBI

[155] Google Scholar

[ref41] 41. Hellemans J, Vandesompele J. Selection of reliable reference genes for RT-qPCR analysis. Methods Mol Biol. 2014. 1160:19–26. pmid:24740218
View Article
PubMed/NCBI
Google Scholar

[157] View Article

[158] PubMed/NCBI

[159] Google Scholar

[ref42] 42. Nwosu ZC, Battello N, Rothley M, Piorońska W, Sitek B, Ebert MP, et al. Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. J Exp Clin Cancer Res. 2018;37(1):211. pmid:30176945
View Article
PubMed/NCBI
Google Scholar

[161] View Article

[162] PubMed/NCBI

[163] Google Scholar

[ref43] 43. Li T, Zhu J, Wang X, Chen G, Sun L, Zuo S, et al. Long non‑coding RNA lncTCF7 activates the Wnt/β‑catenin pathway to promote metastasis and invasion in colorectal cancer. Oncol Lett. 2017;14(6):7384–90. pmid:29344178
View Article
PubMed/NCBI
Google Scholar

[165] View Article

[166] PubMed/NCBI

[167] Google Scholar

[ref44] 44. Ferreira E, Cronjé MJ. Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced MCF-7 breast cancer cells. Mol Biotechnol. 2012;50(2):121–8. pmid:21681549
View Article
PubMed/NCBI
Google Scholar

[169] View Article

[170] PubMed/NCBI

[171] Google Scholar

[ref45] 45. McNeill RE, Miller N, Kerin MJ. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol. 2007;8:107. pmid:18042273
View Article
PubMed/NCBI
Google Scholar

[173] View Article

[174] PubMed/NCBI

[175] Google Scholar

[ref46] 46. Revillion F, Pawlowski V, Hornez L, Peyrat J-P. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer. 2000;36(8):1038–42. pmid:10885609
View Article
PubMed/NCBI
Google Scholar

[177] View Article

[178] PubMed/NCBI

[179] Google Scholar

[ref47] 47. Valenti MT, Bertoldo F, Dalle Carbonare L, Azzarello G, Zenari S, Zanatta M, et al. The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? BMC Cancer. 2006;6:49. pmid:16515701
View Article
PubMed/NCBI
Google Scholar

[181] View Article

[182] PubMed/NCBI

[183] Google Scholar

[ref48] 48. Kılıç Y, Celebiler A, Sakızlı M. Selecting housekeeping genes as references for the normalization of quantitative PCR data in breast cancer. Clin Transl Oncol. 2014;16(2):184–90. pmid:23720140
View Article
PubMed/NCBI
Google Scholar

[185] View Article

[186] PubMed/NCBI

[187] Google Scholar

[ref49] 49. Majidzadeh-A K, Esmaeili R, Abdoli N. TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer. BMC Res Notes. 2011;4:215. pmid:21702980
View Article
PubMed/NCBI
Google Scholar

[189] View Article

[190] PubMed/NCBI

[191] Google Scholar

[ref50] 50. Hashemi A, Roohvand F, Ghahremani M-H. Selection of valid reference genes for expression studies of hepatic cell lines under IFN-α treatment. Biochem Biophys Res Commun. 2012;426(4):649–53. pmid:22982679
View Article
PubMed/NCBI
Google Scholar

[193] View Article

[194] PubMed/NCBI

[195] Google Scholar

[ref51] 51. Jain N, Nitisa D, Pirsko V, Cakstina I. Selecting suitable reference genes for qPCR normalization: a comprehensive analysis in MCF-7 breast cancer cell line. BMC Mol Cell Biol. 2020;21(1):68. pmid:32977762
View Article
PubMed/NCBI
Google Scholar

[197] View Article

[198] PubMed/NCBI

[199] Google Scholar

[ref52] 52. Liu L-L, Zhao H, Ma T-F, Ge F, Chen C-S, Zhang Y-P. Identification of valid reference genes for the normalization of RT-qPCR expression studies in human breast cancer cell lines treated with and without transient transfection. PloS One. 2015;10(1):e0117058. pmid:25617865
View Article
PubMed/NCBI
Google Scholar

[201] View Article

[202] PubMed/NCBI

[203] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Cell culture

Selection of reference genes, designing the primer pairs, and calculation of PCR efficiency

Isolation of total RNA and synthesis of complementary DNA (cDNA)

RT-qPCR

Reference genes stability analysis

Results

Expression status of nominee reference genes in hepatic and breast cancer cell lines

Stability status analysis of nominee reference genes employing geNorm excel-based software

Stability status analysis of nominee reference genes employing NormFinder excel-based software

Stability status analysis of nominee reference genes employing BestKeeper excel-based software

Stability status analysis of nominee reference genes employing RefFinder tool

The optimum number of reference genes for reliable normalization of RT-qPCR

Discussion

Conclusion

Supporting information

S1 Fig. Uncropped and unprocessed images of 1% agarose gel electrophoresis with the indicated areas that are presented in Fig 1a and 1b of the article.

References